126 related articles for article (PubMed ID: 6547728)
21. I alpha, 25-Dihydroxyvitamin D3 receptor in the X-linked hypophosphatemic mouse.
Seino Y; Sierra RI; Ichikawa M; Avioli LV
Endocrinology; 1982 Jul; 111(1):329-31. PubMed ID: 6282570
[TBL] [Abstract][Full Text] [Related]
22. Renal phosphate transport and vitamin D metabolism in X-linked hypophosphatemic Gy mice: responses to phosphate deprivation.
Tenenhouse HS; Meyer RA; Mandla S; Meyer MH; Gray RW
Endocrinology; 1992 Jul; 131(1):51-6. PubMed ID: 1612032
[TBL] [Abstract][Full Text] [Related]
23. Activity of renal 25-hydroxyvitamin D3-1 alpha-hydroxylase in a case of X-linked hypophosphataemic rickets.
Seino Y; Satomura K; Yamaoka K; Tanaka Y; Tanaka H; Yamamoto T; Ishida M; Yabuuchi H
Eur J Pediatr; 1984 Aug; 142(3):219-22. PubMed ID: 6540679
[TBL] [Abstract][Full Text] [Related]
24. Clinical and biochemical findings in parents of children with vitamin D-dependent rickets Type II.
Yokota I; Takeda E; Ito M; Kobashi H; Saijo T; Kuroda Y
J Inherit Metab Dis; 1991; 14(2):231-40. PubMed ID: 1653381
[TBL] [Abstract][Full Text] [Related]
25. The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing vitamin D receptor mutations.
Nguyen TM; Lieberherr M; Fritsch J; Guillozo H; Alvarez ML; Fitouri Z; Jehan F; Garabédian M
J Biol Chem; 2004 Feb; 279(9):7591-7. PubMed ID: 14665637
[TBL] [Abstract][Full Text] [Related]
26. Hereditary resistance to 1,25-dihydroxyvitamin D: clinical and radiological improvement during high-dose oral calcium therapy.
Sakati N; Woodhouse NJ; Niles N; Harfi H; de Grange DA; Marx S
Horm Res; 1986; 24(4):280-7. PubMed ID: 3023230
[TBL] [Abstract][Full Text] [Related]
27. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.
Sullivan W; Carpenter T; Glorieux F; Travers R; Insogna K
J Clin Endocrinol Metab; 1992 Sep; 75(3):879-85. PubMed ID: 1517380
[TBL] [Abstract][Full Text] [Related]
28. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness.
Malloy PJ; Eccleshall TR; Gross C; Van Maldergem L; Bouillon R; Feldman D
J Clin Invest; 1997 Jan; 99(2):297-304. PubMed ID: 9005998
[TBL] [Abstract][Full Text] [Related]
29. Normal vitamin D receptor concentration and responsiveness to 1, 25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria.
Zerwekh JE; Reed BY; Heller HJ; González GB; Haussler MR; Pak CY
Miner Electrolyte Metab; 1998; 24(5):307-13. PubMed ID: 9705566
[TBL] [Abstract][Full Text] [Related]
30. Modulation of 1,25-dihydroxyvitamin D3 receptor binding and action by sodium butyrate in cultured pig kidney cells (LLC-PK1).
Costa EM; Feldman D
J Bone Miner Res; 1987 Apr; 2(2):151-9. PubMed ID: 2843001
[TBL] [Abstract][Full Text] [Related]
31. Decreased nuclear uptake of 1,25-dihydroxyvitamin D3 by duodenal mucosal cells in the X-linked hypophosphatemic mouse.
Yamamoto T; Seino Y; Yamaoka K; Yabuuchi H
Endocrinology; 1985 Nov; 117(5):2252-4. PubMed ID: 2995011
[TBL] [Abstract][Full Text] [Related]
32. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets.
Lin NU; Malloy PJ; Sakati N; al-Ashwal A; Feldman D
J Clin Endocrinol Metab; 1996 Jul; 81(7):2564-9. PubMed ID: 8675579
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D.
Marx SJ; Bliziotes MM; Nanes M
Clin Endocrinol (Oxf); 1986 Oct; 25(4):373-81. PubMed ID: 3040300
[TBL] [Abstract][Full Text] [Related]
34. Normal regulation of calcitriol production in Gy mice. Evidence for biochemical heterogeneity in the X-linked hypophosphatemic diseases.
Davidai GA; Nesbitt T; Drezner MK
J Clin Invest; 1990 Feb; 85(2):334-9. PubMed ID: 2153705
[TBL] [Abstract][Full Text] [Related]
35. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells.
Costa EM; Hirst MA; Feldman D
Endocrinology; 1985 Nov; 117(5):2203-10. PubMed ID: 2995009
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in pediatric metabolic bone disease: the consequences of altered phosphate homeostasis in renal insufficiency and hypophosphatemic vitamin D-resistant rickets.
Pettifor JM
Bone Miner; 1990 Jun; 9(3):199-214. PubMed ID: 2163713
[TBL] [Abstract][Full Text] [Related]
37. Decreased concentration of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with X-linked hypophosphatemic rickets: effect of phosphate supplementation.
Nakajima S; Yamaoka K; Yamamoto T; Okada S; Tanaka H; Seino Y
Bone Miner; 1990 Sep; 10(3):201-9. PubMed ID: 2171704
[TBL] [Abstract][Full Text] [Related]
38. Hereditary resistance to 1,25-dihydroxyvitamin D.
Marx SJ; Liberman UA; Eil C; Gamblin GT; DeGrange DA; Balsan S
Recent Prog Horm Res; 1984; 40():589-620. PubMed ID: 6091196
[No Abstract] [Full Text] [Related]
39. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs.
Musiol IM; Feldman D
Endocrinology; 1997 Jan; 138(1):12-8. PubMed ID: 8977379
[TBL] [Abstract][Full Text] [Related]
40. Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets.
Yamaoka K; Tanaka H; Kurose H; Shima M; Ozono K; Nakajima S; Seino Y
Bone Miner; 1989 Sep; 7(2):159-69. PubMed ID: 2804451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
